Cite
Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.
MLA
Evang, Johan Arild, et al. “Reduced Levels of E-Cadherin Correlate with Progression of Corticotroph Pituitary Tumours.” Clinical Endocrinology, vol. 75, no. 6, Dec. 2011, pp. 811–18. EBSCOhost, https://doi.org/10.1111/j.1365-2265.2011.04109.x.
APA
Evang, J. A., Berg, J. P., Casar-Borota, O., Lekva, T., Kringen, M. K., Ramm-Pettersen, J., & Bollerslev, J. (2011). Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours. Clinical Endocrinology, 75(6), 811–818. https://doi.org/10.1111/j.1365-2265.2011.04109.x
Chicago
Evang, Johan Arild, Jens Petter Berg, Olivera Casar-Borota, Tove Lekva, Marianne Kristiansen Kringen, Jon Ramm-Pettersen, and Jens Bollerslev. 2011. “Reduced Levels of E-Cadherin Correlate with Progression of Corticotroph Pituitary Tumours.” Clinical Endocrinology 75 (6): 811–18. doi:10.1111/j.1365-2265.2011.04109.x.